• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4607994)   Today's Articles (9)   Subscriber (49375)
For: Sun LZ, Li W, Chen C, Zhao J. Advanced Utilization of Intermediate Endpoints for Making Optimized Cost-Effective Decisions in Seamless Phase II/III Oncology Trials. Stat Biopharm Res 2019. [DOI: 10.1080/19466315.2019.1665578] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Number Cited by Other Article(s)
1
Bai X, Deng Q, Li W. Conditional bias adjusted estimator of treatment effect in 2-in-1 adaptive design. J Biopharm Stat 2024:1-20. [PMID: 38841980 DOI: 10.1080/10543406.2024.2359147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Accepted: 05/12/2024] [Indexed: 06/07/2024]
2
Chen C, Sun L, Zhang X. A promising biomarker adaptive Phase 2/3 design - Explained and expanded. Contemp Clin Trials Commun 2023;36:101229. [PMID: 38034840 PMCID: PMC10684793 DOI: 10.1016/j.conctc.2023.101229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 10/14/2023] [Accepted: 11/04/2023] [Indexed: 12/02/2023]  Open
3
Duputel B, Stallard N, Montestruc F, Zohar S, Ursino M. Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial. Stat Methods Med Res 2023;32:963-977. [PMID: 36919403 PMCID: PMC10521165 DOI: 10.1177/09622802231160554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023]
4
Zhang X, Jia H, Xing L, Chen C. Application of group sequential methods to the 2-in-1 design and its extensions for interim monitoring. Stat Biopharm Res 2023. [DOI: 10.1080/19466315.2023.2197402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/01/2023]
5
Bai X, Deng Q. Incorporating Intermediate Endpoint in Two-stage Design Decision Making. Stat Biopharm Res 2022. [DOI: 10.1080/19466315.2022.2108134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
6
Li W, Zhou H, Jia C, Sun L. Family-wise type I error rate control for an extended 2-in-1 design with graphical approach in oncology drug development. Contemp Clin Trials 2022;119:106846. [PMID: 35803494 DOI: 10.1016/j.cct.2022.106846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 05/27/2022] [Accepted: 07/02/2022] [Indexed: 11/03/2022]
7
Li Q, Lin J, Liu M, Wu L, Liu Y. Using Surrogate Endpoints in Adaptive Designs with Delayed Treatment Effect. Stat Biopharm Res 2021. [DOI: 10.1080/19466315.2021.1938203] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
8
Li W, Bai X, Deng Q, Liu F, Chen C. Estimation of treatment effect in 2-in-1 adaptive design and some of its extensions. Stat Med 2021;40:2556-2577. [PMID: 33723865 DOI: 10.1002/sim.8917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Revised: 01/26/2021] [Accepted: 02/03/2021] [Indexed: 11/06/2022]
9
Li Q, Lin J, Lin Y. Adaptive design implementation in confirmatory trials: methods, practical considerations and case studies. Contemp Clin Trials 2020;98:106096. [PMID: 32739496 DOI: 10.1016/j.cct.2020.106096] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 07/13/2020] [Accepted: 07/27/2020] [Indexed: 10/23/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA